July 2017 Vol XLI Issue 7

Previous Month


FRONTIERS IN ENDOSCOPY, SERIES #37

Melanoma Metastatic to the Ampulla of Vater Diagnosed via EUS-Guided Core Biopsy

Zoey Bridges, Isaac Lloyd, Douglas G. Adler

In this article, we discuss a rare presentation of metastatic melanoma to the ampulla where an endoscopy and endoscopic ultrasound were vital in evaluating the patient and obtaining core biopsies of the lesion. Proper tissue acquisition was made possible with EUS-FNB for pathology interpretation, showing the value of this technique.



NUTRITION ISSUES IN GASTROENTEROLOGY, SERIES #165

Reinfusion of Gastrointestinal Secretions - The Bedside Experience

Amy J. Berry

Both pancreatic enzymes and bile salts are necessary for complete absorption of dietary fat. While pancreatic enzymes are available to replace insufficient pancreatic secretion, there is no replacement for bile salts. Unabated external loss of upper intestinal secretions can result in dehydration, acid/base imbalance, electrolyte abnormalities as well as malabsorption. This article describes the reinfusion of GI secretions, various methods of reinfusion, as well as potential and significant pitfalls when embarking on this form of treatment.



DISPATCHES FROM THE GUILD CONFERENCE, SERIES #6

Antiviral Therapy for Patients with Immune Active Hepatitis B - What, When and is Forever?

Tatyana Kushner, Norah Terrault

Hepatitis B is the most common chronic viral infection in the world and leads to significant complications. Antiviral therapies currently available are highly effective in achieving viral suppression, however if and when providers can consider discontinuation of antiviral therapy continue to evolve. Increasingly, there is emphasis on treating until HBsAg loss occurs, but this means many patients will be on life-long therapy. A finite duration of therapy is attractive to patients and providers but one must consider the potential risks when stopping treatment. New data continue to inform this question and are reflected in this review.



A CASE REPORT

Internal Biliary Fistula Secondary to Cushing's Ulcer in a Child

Allison Ta, Suchitra Hourigan, Otto Louis-Jacques



Departments Section


Medical Bulletin Board

ARIES PHARMACEUTICALS, INC. LAUNCHES ELEVIEW™ FOR USE IN GASTROINTESTINAL ENDOSCOPIC PROCEDURES
Novel Development in Submucosal Injection Agents Elevates Lesions to Facilitate Removal

SAN DIEGO - Aries Pharmaceuticals, Inc. (Aries) has announced the launch and commercial availability of its first product, Eleview™, a novel, ready to use, submucosal injectable composition for use in the easy and safe endoscopic removal of polyps, adenomas, and early stage cancers, and other lesions in the gastrointestinal (GI) tract.



HYPER-IMPLANTETM, REPLENISS®, FORTEFYTM & FLORA-ELITE®
Probiotic Dietary Supplements from InterPlexus, Inc.

Probiotic and synbiotic supplements from InterPlexus, Inc. provide commensal flora to support gastrointestinal, dermatological, and immune systemhealth.* Multiple strains are combined in each product to re-inoculate with new colonies as well as maintain current healthy colonies of intestinal flora.



Meetings Calendar

July 22, 2017 – Mastering Clinical Challenges and Emerging Therapies in IBD
October 13-18, 2017 World Congress of Gastroenterology (WCOG) at ACG 2017
November 9-11, 2017 - Advances in Inflammatory Bowel Diseases - Multidisciplinary Approaches to IBD Patient - Centered Care New Presenters, New Content, A New Year